• Exchange: Xetra
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Nobel Biocare Holding AG

+ Add to Watchlist


14.026 EUR 0.039 0.28%

As of 13:29:54 ET on 09/19/2014.

Snapshot for Nobel Biocare Holding AG (NLB1)

Open: 14.050 Day's Range: 14.026 - 14.104 Volume: 602
Previous Close: 14.065 52wk Range: 9.697 - 15.260 1-Yr Rtn: +33.34%

Stock Chart for NLB1

No chart data available.
  • NLB1:GR 14.026
  • 1D
  • 1M
  • 1Y
Interactive NLB1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NLB1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 33.0802
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.4240
Est. PEG Ratio 1.8264
Market Cap (M EUR) 1,736.20
Shares Outstanding (M) 123.78
30 Day Average Volume 2,222
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.17%
Cash Dividend (CHF) 0.2000
Dividend Ex-Date 03/28/2014
5 Year Dividend Growth -14.61%
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NLB1

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NLB1

Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.

Richard T LaubeChief Executive OfficerOliver WalkerChief Financial Officer
Hans GeiselhoringerExec VP:Global ResearchMelker NilssonExec VP:Global Customer
More Company Profile & Key Executives for NLB1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil